Vittarthaa focuses on creating and advancing innovative drugs for the treatment of diseases: Urea Cycle Disorder (UCD), Hepatic Encephalopathy and Gout. Vittarthaa utilizes Discovery and Development platform to validate theraupetic tablets against which the challenges related to potency, selectivity, pharmacokinetics and patentability, that remain a challenge. At Vittarthaa, we develop best-in-class drugs for various targets.

Vittarthaa Pipeline: